NSC |
Compound |
Enrichment |
Correlation |
NSC 728040 |
2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline |
0.00182957917645007 |
0.31486426 |
NSC 736079 |
4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine |
0.00182957917645007 |
0.44951221 |
NSC 736081 |
4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine |
0.00182957917645007 |
0.39467163 |
NSC 743432 |
2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione |
0.00182957917645007 |
0.44794494 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.00216534295403404 |
0.51050356 |
NSC 678040 |
Methanone, (tricyclo[3.3.1.1(3,7)]decan-1-yl) [3-(3-nitrophenyl)-2-oxiranyl]- |
0.00216534295403404 |
0.30045127 |
NSC 687578 |
Null |
0.00216534295403404 |
0.25775457 |
NSC 690248 |
Null |
0.00216534295403404 |
0.49231713 |
NSC 692574 |
Null |
0.00216534295403404 |
0.66578398 |
NSC 693867 |
Null |
0.00216534295403404 |
0.50531606 |